Concurrent Morning Panels: 11:30 to 12:45 p.m.
Moderator: Professor Cliff Cramer
Jim Boylan ('94), Managing Director, Merrill Lynch
Perry Karsen, SVP, Business Development, Celgene
Tamar Howson (’80), Exec. Vice President, Lexicon Pharma
Dan Tully, Managing Director, Altaris Capital Partners
• How are successful companies organized to best identify, pursue, negotiate, and execute M&A and other business development initiatives?
• What is the role of private equity in healthcare M&A? How has it changed with the recent problems with sub-prime debt?
Moderator: Professor Linda Green
Karen Collins, VP Quality, NY Presbyterian
Lorna Friedman, Chief Medical Officer, CIGNA
Michael K. Gusmano, Assistant Professor of Health Policy & Management, Mailman School of Public Health
J. Brent Pawlecki, Corp. Med. Director, Pitney Bowes
• Which strategies are employers, insurers and providers pursuing to slow the growth of employee healthcare costs and improve health outcomes?
• What actions are major hospitals taking to reduce medical errors and improve outcomes?
• How effective have consumer-driven healthcare initiatives been?
• Why is the healthcare industry slow to adopt information technology, and what can be done to overcome such barriers?
Concurrent Afternoon Panels: 2:45 to 4:00 p.m.
Moderator: Jacques Mulder, Principal, Deloitte Consulting
Robert Bazemore, VP Bio-Worldwide, Johnson & Johnson Pharma Services
Charles Beever, Vice President, Booz Allen Hamilton
Andreas Fibig, SVP/GM, US Pharma, Pfizer
Richard Johnson, Managing Partner, Hudson Medical Communications
Phillip Satow, Chairman/CEO, JDS Pharmaceuticals
• What strategies are pharma/biotech companies pursuing to best position products with insurers, PBMs and other MCOs?